PFE
Income statement / Annual
Last year (2024), Pfizer Inc.'s total revenue was $63.63 B,
an increase of 8.77% from the previous year.
In 2024, Pfizer Inc.'s net income was $8.03 B.
See Pfizer Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$63.63 B |
$58.50 B |
$100.33 B |
$81.29 B |
$41.91 B |
$51.75 B |
$53.65 B |
$52.55 B |
$52.82 B |
$48.85 B |
| Cost of Revenue |
$16.42 B
|
$29.69 B
|
$34.34 B
|
$30.82 B
|
$8.69 B
|
$10.22 B
|
$11.25 B
|
$11.24 B
|
$12.33 B
|
$9.65 B
|
| Gross Profit |
$47.21 B
|
$28.81 B
|
$65.99 B
|
$50.47 B
|
$33.22 B
|
$41.53 B
|
$42.40 B
|
$41.31 B
|
$40.50 B
|
$39.20 B
|
| Gross Profit Ratio |
0.74
|
0.49
|
0.66
|
0.62
|
0.79
|
0.8
|
0.79
|
0.79
|
0.77
|
0.8
|
| Research and Development Expenses |
$10.82 B
|
$10.68 B
|
$11.43 B
|
$13.83 B
|
$9.41 B
|
$8.65 B
|
$8.01 B
|
$7.66 B
|
$7.87 B
|
$7.69 B
|
| General & Administrative Expenses |
$0.00
|
$11.07 B
|
$10.88 B
|
$10.70 B
|
$9.82 B
|
$12.05 B
|
$11.76 B
|
$11.68 B
|
$11.64 B
|
$11.71 B
|
| Selling & Marketing Expenses |
$0.00
|
$3.70 B
|
$2.80 B
|
$2.00 B
|
$1.80 B
|
$2.30 B
|
$2.70 B
|
$3.10 B
|
$3.20 B
|
$3.10 B
|
| Selling, General & Administrative Expenses |
$14.73 B
|
$14.77 B
|
$13.68 B
|
$12.70 B
|
$11.62 B
|
$14.35 B
|
$14.46 B
|
$14.78 B
|
$14.84 B
|
$14.81 B
|
| Other Expenses |
$0.00
|
$0.00
|
$3.61 B
|
$3.70 B
|
$3.44 B
|
$4.61 B
|
$1.14 B
|
$981.00 M
|
$820.00 M
|
$519.00 M
|
| Operating Expenses |
$25.55 B
|
$25.45 B
|
$28.71 B
|
$30.23 B
|
$24.46 B
|
$27.61 B
|
$27.35 B
|
$27.20 B
|
$26.77 B
|
$26.23 B
|
| Cost And Expenses |
$42.12 B
|
$55.14 B
|
$63.06 B
|
$61.05 B
|
$33.15 B
|
$37.83 B
|
$38.60 B
|
$38.44 B
|
$39.09 B
|
$35.88 B
|
| Interest Income |
$545.00 M
|
$1.62 B
|
$251.00 M
|
$36.00 M
|
$73.00 M
|
$226.00 M
|
$333.00 M
|
$391.00 M
|
$470.00 M
|
$471.00 M
|
| Interest Expense |
$3.09 B
|
$2.21 B
|
$1.24 B
|
$1.29 B
|
$1.45 B
|
$1.57 B
|
$1.32 B
|
$1.27 B
|
$1.19 B
|
$1.20 B
|
| Depreciation & Amortization |
$7.01 B
|
$6.29 B
|
$5.06 B
|
$5.19 B
|
$4.68 B
|
$5.80 B
|
$6.38 B
|
$6.27 B
|
$5.76 B
|
$3.73 B
|
| EBITDA |
$18.13 B |
$9.56 B |
$41.03 B |
$30.79 B |
$13.17 B |
$18.85 B |
$19.59 B |
$19.84 B |
$15.29 B |
$15.32 B |
| EBITDA Ratio |
0.28
|
0.16
|
0.43
|
0.35
|
0.34
|
0.38
|
0.4
|
0.39
|
0.36
|
0.36
|
| Operating Income Ratio |
0.23
|
0.06
|
0.4
|
0.31
|
0.25
|
0.29
|
0.28
|
0.27
|
0.26
|
0.27
|
| Total Other Income/Expenses Net |
-$6.92 B
|
-$2.30 B
|
-$2.54 B
|
-$2.67 B
|
-$3.59 B
|
-$3.65 B
|
$5.16 B
|
-$1.77 B
|
-$5.36 B
|
-$4.01 B
|
| Income Before Tax |
$8.02 B
|
$1.06 B
|
$34.73 B
|
$24.31 B
|
$7.50 B
|
$17.68 B
|
$11.89 B
|
$12.31 B
|
$8.35 B
|
$8.97 B
|
| Income Before Tax Ratio |
0.13
|
0.02
|
0.35
|
0.3
|
0.18
|
0.34
|
0.22
|
0.23
|
0.16
|
0.18
|
| Income Tax Expense |
-$28.00 M
|
-$1.11 B
|
$3.33 B
|
$1.85 B
|
$477.00 M
|
$1.38 B
|
$706.00 M
|
-$9.05 B
|
$1.12 B
|
$1.99 B
|
| Net Income |
$8.03 B
|
$2.12 B
|
$31.37 B
|
$21.98 B
|
$7.02 B
|
$16.27 B
|
$11.15 B
|
$21.31 B
|
$7.22 B
|
$6.96 B
|
| Net Income Ratio |
0.13
|
0.04
|
0.31
|
0.27
|
0.17
|
0.31
|
0.21
|
0.41
|
0.14
|
0.14
|
| EPS |
1.42 |
0.38 |
5.59 |
3.95 |
1.26 |
2.92 |
1.9 |
3.57 |
1.18 |
1.13 |
| EPS Diluted |
1.41 |
0.37 |
5.47 |
3.88 |
1.25 |
2.87 |
1.87 |
3.52 |
1.17 |
1.11 |
| Weighted Average Shares Out |
$5.66 B
|
$5.64 B
|
$5.61 B
|
$5.60 B
|
$5.56 B
|
$5.57 B
|
$5.87 B
|
$5.97 B
|
$6.09 B
|
$6.18 B
|
| Weighted Average Shares Out Diluted |
$5.70 B
|
$5.71 B
|
$5.73 B
|
$5.71 B
|
$5.63 B
|
$5.68 B
|
$5.98 B
|
$6.06 B
|
$6.16 B
|
$6.26 B
|
| Link |
|
|
|
|
|
|
|
|
|
|
